Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Future Oncology (London, England)|July 24, 2014
HER2 in solid tumors: more than 10 years under the microscope; where are we now?Vittoria Martin, Federico Cappuzzo, Luca Mazzucchelli, et al.
Pathology Research International|March 27, 2012
Internal Quality Assurance Program for ERBB2 (HER2) Testing Improves the Selection of Breast Cancer Patients for Treatment with TrastuzumabVittoria Martin, Antonella Camponovo, Morena Ghisletta, et al.
Tumori|October 26, 2010
Molecular characterization and response to cetuximab in a patient with refractory squamous cell anal carcinomaSara De Dosso, Vittoria Martin, Elena Zanellato, et al.
Hematological Oncology|May 14, 2014
Chromosomal aberrations of cancer-testis antigens in myeloma patientsAlessandra Curioni-Fontecedro, Vittoria Martin, Alexander Vogetseder, et al.
BMC Cancer|November 11, 2020
Functional and clinical significance of ROR1 in lung adenocarcinomaGiovanna Schiavone, Samantha Epistolio, Vittoria Martin, et al.
BMC Cancer|December 8, 2020
Correction to: Functional and clinical significance of ROR1 in lung adenocarcinomaGiovanna Schiavone, Samantha Epistolio, Vittoria Martin, et al.
Hematological Oncology|February 5, 2014
The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomasDavide Soldini, Antoin Georgis, Chiara Montagna, et al.
Leukemia & Lymphoma|February 28, 2007
Cyclin-dependent kinase inhibitor seliciclib shows in vitro activity in diffuse large B-cell lymphomasKatia Lacrima, Andrea Rinaldi, Sara Vignati, et al.
Pageof 3